Abstract
Lung cancer is a global public health concern with the highest morbidity and mortality among all cancers. Biomarkers can be used for early lung cancer detection, prognostication and optimal treatment. Research on biomarkers will enable more effective therapy for each individual patient. Great progress has been made in biomarker discovery with more understanding involved in lung cancer. Lung cancer biomarkers can be classified into Proteins, DNAs, Epigenomics, and RNAs according to their biochemical properties. Here, we will discuss the most common biomarkers for lung cancer.
Keywords: Biomarker, diagnosis, lung cancer, prognosis.
Current Signal Transduction Therapy
Title:Current Biomarkers for Lung Cancer
Volume: 9 Issue: 3
Author(s): Kaifei Wang, Zhaohui Huang, Ruilin Wang, Jin Qian, Zhenhua Zuo, Yaping Li, Xiaoyan Yao and Xizhou Guan
Affiliation:
Keywords: Biomarker, diagnosis, lung cancer, prognosis.
Abstract: Lung cancer is a global public health concern with the highest morbidity and mortality among all cancers. Biomarkers can be used for early lung cancer detection, prognostication and optimal treatment. Research on biomarkers will enable more effective therapy for each individual patient. Great progress has been made in biomarker discovery with more understanding involved in lung cancer. Lung cancer biomarkers can be classified into Proteins, DNAs, Epigenomics, and RNAs according to their biochemical properties. Here, we will discuss the most common biomarkers for lung cancer.
Export Options
About this article
Cite this article as:
Wang Kaifei, Huang Zhaohui, Wang Ruilin, Qian Jin, Zuo Zhenhua, Li Yaping, Yao Xiaoyan and Guan Xizhou, Current Biomarkers for Lung Cancer, Current Signal Transduction Therapy 2014; 9 (3) . https://dx.doi.org/10.2174/1574362409666140911225531
DOI https://dx.doi.org/10.2174/1574362409666140911225531 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Targeting the Epidermal Growth Factor Receptor in Glioblastoma Treatment
Current Signal Transduction Therapy Evolutionary Orthodoxy: How and Why the Evolutionary Theory of Aging Went Astray
Current Aging Science Amyloidogenicity of p53: A Hidden Link Between Protein Misfolding and Cancer
Current Protein & Peptide Science Meet Our Editorial Board Member
Current Medicinal Chemistry Goniothalamin-Related Styryl Lactones: Isolation, Synthesis, Biological Activity and Mode of Action
Current Medicinal Chemistry Involvement of Cannabinoids in Cellular Proliferation
Mini-Reviews in Medicinal Chemistry Blockade of Neoangiogenesis, a New and Promising Technique to Control the Growth of Malignant Tumors and their Metastases
Current Vascular Pharmacology Spinophilin: A New Tumor Suppressor at 17q21
Current Molecular Medicine Stimuli-Responsive Nanoparticles for siRNA Delivery
Current Pharmaceutical Design Oncorine, the World First Oncolytic Virus Medicine and its Update in China
Current Cancer Drug Targets Subject Index to Volume 9
Current Pharmaceutical Design Design, Synthesis and Antiproliferative Activity of Novel Benzothiazole Derivatives Conjugated with Semicarbazone Scaffold
Medicinal Chemistry Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment
Current Pharmaceutical Design Imaging of Cyclooxygenase-2 (COX-2) Expression: Potential Use in Diagnosis and Drug Evaluation
Current Pharmaceutical Design A Suicide Gene Therapy Combining the Improvement of Cyclophosphamide Tumor Cytotoxicity and the Development of an Anti-Tumor Immune Response
Current Gene Therapy Dual-Targeted Molecular Probes for Cancer Imaging
Current Pharmaceutical Biotechnology RNA Interference-Mediated Validation of Survivin and Apollon/BRUCE as New Therapeutic Targets for Cancer Therapy
Current Topics in Medicinal Chemistry Tankyrase as a Novel Molecular Target in Cancer and Fibrotic Diseases
Current Drug Targets Targeted Therapy of the Insulin-Like Growth Factor-1 Receptor in Cancer
Combinatorial Chemistry & High Throughput Screening Prostaglandin E<sub>2</sub> Receptor 4 (EP4): A Promising Therapeutic Target for the Treatment of Cancer and Inflammatory Diseases
Current Chemical Biology